Aurora Cannabis (TSE:ACB) Stock Price Up 5.8% - Still a Buy?

Key Points

• Aurora Cannabis shares rose 5.8% to C$5.81 in mid-day trading, outperforming recent levels while trading volume fell 47% below its average.
• Analyst sentiment is cautiously positive: the stock has an overall “Moderate Buy” rating, with an average price target of C$6.67. ATB Cormark raised its target to C$7.00, while Canaccord lowered its target to C$5.00 and retained a Buy rating.
• The company remains unprofitable, reporting a quarterly loss of C$0.07 per share, C$67.55 million in revenue, a negative 9.53% net margin, and a negative 5.21% return on equity.

Aurora Cannabis Inc. (TSE:ACB - Get Free Report)'s stock price rose 5.8% during mid-day trading on Tuesday. The company traded as high as C$5.85 and last traded at C$5.81. Approximately 215,864 shares changed hands during trading, a decline of 47% from the average daily volume of 404,221 shares. The stock had previously closed at C$5.49.

Analyst Ratings Changes

ACB has been the topic of several analyst reports. ATB Cormark Capital Markets boosted their target price on Aurora Cannabis from C$5.60 to C$7.00 and gave the stock a "tender" rating in a report on Tuesday, October 6th. BMO Capital Markets upgraded Aurora Cannabis to a "hold" rating in a report on Wednesday, August 5th. Finally, Canaccord Genuity Group reduced their price target on Aurora Cannabis from C$6.50 to C$5.00 and set a "buy" rating for the company in a report on Tuesday, June 30th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of C$6.67.

Aurora Cannabis Price Performance

The firm's fifty day simple moving average is C$5.65 and its 200-day simple moving average is C$4.94. The firm has a market capitalization of C$359.97 million, a PE ratio of -2.99 and a beta of 0.64. The company has a quick ratio of 2.48, a current ratio of 5.36 and a debt-to-equity ratio of 4.30.

Aurora Cannabis (TSE:ACB - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported C($0.07) EPS for the quarter. The firm had revenue of C$67.55 million for the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%. On average, research analysts forecast that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

Aurora Cannabis Company Profile

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty's ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.